B-type natriuretic peptide reverses vascular endothelial insulin resistance and ameliorates dysregulated redox signalling when administered alongside insulin in human atherosclerosis
31 August 2025 (12:15 - 13:00)
Organised by: 
About the speaker
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
2 More presentations in this session
Doctor J. Obergassel (Hamburg, DE)
Doctor A. Kratzer (Berlin, DE)
Access the full session
The Event
ESC Congress 2025
31 August 2025
12:15 CET
You may be interested in
Congress Session
